0000899243-20-026184.txt : 20200923 0000899243-20-026184.hdr.sgml : 20200923 20200923190552 ACCESSION NUMBER: 0000899243-20-026184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200921 FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CureDuchenne Ventures, LLC CENTRAL INDEX KEY: 0001824590 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201193105 BUSINESS ADDRESS: STREET 1: 1400 QUAIL STREET STREET 2: SUITE 110 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 949-872-2552 MAIL ADDRESS: STREET 1: 1400 QUAIL STREET STREET 2: SUITE 110 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-21 1 0001818794 Dyne Therapeutics, Inc. DYN 0001824590 CureDuchenne Ventures, LLC 1400 QUAIL STREET SUITE 110 NEWPORT BEACH CA 92660 0 0 1 0 Common Stock 2020-09-21 4 C 0 602972 A 602972 D Series A Preferred Stock 2020-09-21 4 C 0 2000000 0.00 D Common Stock 602972 0 D On September 21, 2020, the Series A Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. CureDuchenne Ventures, LLC, By: /s/ Debra Miller, Chief Executive Officer 2020-09-23